Delivery Order SPE2DB22D2206-SPE2DB25FFR22
Award Date
2/14/25
Potential Completion Date
3/10/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024 with a ceiling value of $14,788.92 and a completion date of December 6, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation. The contract is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024, with a total ceiling value of $98,387.10 and an ultimate completion date of October 21, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vial 200ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $11,912.50 and is a firm fixed-price delivery order with a completion date of May 7, 2024. The contract is not designated with a set-aside requirement, indicating...
This federal contract award, valued at $1,831.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 10 gram/100 ml vials, with a completion date of February 4, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,377.17 and an ultimate completion date of March 28, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $49,752.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 gram/400 ml vial, a pharmaceutical product, with a performance period through December 6, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $24,876.40 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GAMUNEX-C 40 gram/400 ml vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $192,363.20 and a completion date of October 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $51,945.36 and is a firm fixed-price instrument for the delivery of 4563080315 GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has an ultimate completion date of January 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of GAMUNEX-C 5 GRAM/50 ML VIAL 50ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 22, 2024 with a ceiling value of $1,479.65. The contract has a firm fixed price pricing type and a completion date of November 13, 2024. There is no set-aside designation for this award....